ADI, through Analog Garage, Evonetix
Support for the development of genetic synthesis chips and desktop equipment


Analog Devices (ADI) announced on the 10th that it is expanding its collaboration with Evonetix, which it has been collaborating with since January of last year. Evonetix, a synthetic biology company, is currently developing a desktop platform for scalable, high-fidelity gene synthesis.

ADI is strengthening its support through its corporate innovation lab, Analog Garage, to enable Evonetix to rapidly develop MEMS-based gene synthesis chips and a desktop DNA writer.

For synthetic biology to be useful in the development of new drugs, industrial microorganisms, specialty chemicals, renewable energy, seeds, etc., the ability to mass-produce de novo synthesized genes is necessary. Currently, the lack of this technology is hindering the growth of the related market.

To solve these problems, Evonetix is developing a plug-and-play desktop gene synthesis device. If the gene synthesis chip and device are commercialized, the accuracy, scale, and speed of gene synthesis are expected to improve in the future.